Discover Tenders by Profile Sections Sector

Find the most relevant tenders for Profile Sections. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Profile Sections tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Profile Sections tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Bimatoprost Atc Code S01Ee03

Deadline: 27 Sep 2027

Germany

Ref. No.: 21270202

EMD:Ref Document

Bid Value: Ref Document

467 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Golimumab Atc Code According To Who L04Ab06

Deadline: 31 Dec 2026

Germany

Ref. No.: 21237966

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Flecainide Atc Code According To Who C01Bc04

Deadline: 31 Jan 2028

Germany

Ref. No.: 21237089

EMD:Ref Document

Bid Value: Ref Document

593 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Tocilizumab Atc Code According To Who L04Ac07

Deadline: 01 Jan 2027

Germany

Ref. No.: 21230544

EMD:Ref Document

Bid Value: Ref Document

198 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Leuprorelin Atc Code According To Who L02Ae02

Deadline: 01 Feb 2028

Germany

Ref. No.: 21229165

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Flecainide Atc Code According To Who C01Bc04

Deadline: 01 Feb 2028

Germany

Ref. No.: 21227936

EMD:Ref Document

Bid Value: Ref Document

594 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By Means Of An Open House Model To The Active Ingredient Tencilizumab Atc Code According To Who L04Ac07

Deadline: 31 Dec 2026

Germany

Ref. No.: 21223724

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By Means Of An Open House Model To The Active Ingredient Leuprorelin Atc Code According To Who L02Ae02

Deadline: 31 Jan 2028

Germany

Ref. No.: 21210002

EMD:Ref Document

Bid Value: Ref Document

593 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Golimumab Atc Code According To Who L04Ab06

Deadline: 31 Dec 2026

Germany

Ref. No.: 21207981

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Leuprorelin Atc Code According To Who L02Ae02

Deadline: 31 Jan 2028

Germany

Ref. No.: 21207964

EMD:Ref Document

Bid Value: Ref Document

593 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By Means Of An Open House Model To The Active Ingredient Tencilizumab Atc Code According To Who L04Ac07

Deadline: 31 Dec 2026

Germany

Ref. No.: 21207405

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Tocilizumab Atc Code According To Who L04Ac07

Deadline: 31 Dec 2026

Germany

Ref. No.: 21206738

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Flecainide Atc Code According To Who C01Bc04

Deadline: 31 Jan 2028

Germany

Ref. No.: 21206724

EMD:Ref Document

Bid Value: Ref Document

593 Days Left

Completion Not Excl Pharmaceutical Discount Club According To Section 130A 8 Sgb V By Means Of An Open House Model To The Active Ingredient Leuprorelin Atc Code According To Who L02Ae02

Deadline: 31 Jan 2028

Germany

Ref. No.: 21206716

EMD:Ref Document

Bid Value: Ref Document

593 Days Left

Open House Discount Contracts 2025 14 Guanfacin Ret Effectiveness 1 4 Mg

Deadline: 31 Oct 2026

Germany

Ref. No.: 21188588

EMD:Ref Document

Bid Value: Ref Document

136 Days Left

Showing 31681 to 31695 of 33769 results

‹
1
2
...
2110
2111
2112
2113
2114
2115
2116
...
2251
2252
›

Discover Tenders by Profile Sections Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Profile Sections Sector

Filter Your Search

FREE Trial plan for all new users!